Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07065773
PHASE2

Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe Onychomycosis

Sponsor: Vanda Pharmaceuticals

View on ClinicalTrials.gov

Summary

This is a multicenter, open label study designed to evaluate the safety, tolerability, and efficacy of topically administered VTR-297 solution. The efficacy objectives of the study will be assessed using fungal culture testing, Neutral Red Staining (NRS) microscopy examination, and KOH microscopy examination after 4 weeks of treatment with VTR-297.

Official title: An Open Label Study to Investigate the Safety and Tolerability of Trichostatin A in Patients With Mild to Severe Onychomycosis

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2025-05-05

Completion Date

2026-09

Last Updated

2026-02-04

Healthy Volunteers

No

Interventions

DRUG

Trichostatin A

Topical Study Drug

Locations (5)

Vanda Investigational Site

Fremont, California, United States

Vanda Investigational Site

Denver, Colorado, United States

Vanda Investigational Site

New Brighton, Minnesota, United States

Vanda Investigational Site

Pflugerville, Texas, United States

Vanda Investigational Site

Forest, Virginia, United States